26 May 2013
Keywords: coumadin, launched, usa, warfarin, dupont, merck, post-myocardial
Article | 15 May 1995
- Coumadin (warfarin), DuPont Merck's post-myocardial infarction treatment against recurrent MI and thromboembolic events, has been launched in the USA after ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.